September 30, 2026 Cancer immunotherapy, advanced DNA sequencing, Alzheimer’s research and predictive human tissue testing are putting seven healthcare companies on the 2026 watchlist. ImmunityBio, Pacific Biosciences, IGC Pharma, VivoSim…
September 30, 2026 Antibody-drug conjugates are designed to deliver powerful cancer-killing payloads directly to targeted cells, but their precision comes with significant development complexity. For VivoSim Labs Inc. (NASDAQ: VIVS),…
Sept. 30, 2026 Fusion-energy, powered infrastructure, manufactoring and exploration headline the latest developments from NIVF, AMFN, FNGR, GMGMF, AMLM and RETO. American Fusion Inc. (OTCQB: AMFN) released a technical analysis…
Sept. 28, 2026 VivoSim Labs Inc. (NASDAQ: VIVS) is developing human-relevant testing technologies designed to identify unsuccessful drug candidates earlier, potentially improving the economics of pharmaceutical development. With an industry…
Sept. 25, 2026 American Fusion Inc. (OTCQB: AMFN) has filed 21 additional U.S. patent applications, bringing its Texatron™ intellectual-property portfolio to 151 pending U.S. applications, as the company continues testing…
Sept. 25, 2026 From AI data centers and Alzheimer’s research to drug safety testing and humanoid robots, six small-cap companies are approaching developments that could shape their next phase of…
Sept. 24, 2026 Investors are watching DarkHorse Technologies Inc. (NASDAQ: DRK), Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS), Greenland Energy Company (NASDAQ: GLND) and Glucotrack, Inc. (NASDAQ: GCTK) as new…
WILMINGTON, Del., Sept. 24, 2026 DarkHorse Technologies Inc. (NASDAQ: DRK) is advancing its transformation into an AI infrastructure and high-performance computing (HPC) data center company, adding four strategic partners to…
September 22, 2026 – Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) is building momentum in September as a series of developments spanning graphene manufacturing, next-generation batteries, AI data center…
Sept. 23, 2026 PetVivo Holdings, Inc. (OTCQX: PETV) has appointed Jaime K. Pickett, DVM, MBA, and Michael K. Handley to its Board of Directors, adding experience in veterinary care and…
